Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Plain language summary of the ZUMA-7 study of axicabtagene ciloleucel versus standard of care for people with relapsed or refractory large B-cell lymphoma.
Journal: Future oncology (London, England)
Published: January 13, 2025
Tumor gene expression signatures associated with outcome in large B-cell lymphoma treated with CD19-directed CAR T-cell therapy (axicabtagene ciloleucel).
Journal: Frontiers in oncology
Published: October 29, 2024
Axicabtagene Ciloleucel in Large B-Cell Lymphoma. Reply.
Journal: The New England journal of medicine
Published: September 21, 2023
Product Attributes of CAR T-cell Therapy Differentially Associate with Efficacy and Toxicity in Second-line Large B-cell Lymphoma (ZUMA-7).
Journal: Blood cancer discovery
Published: June 30, 2023
Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma.
Journal: The New England journal of medicine
Published: June 05, 2023
Impact of tumor microenvironment on efficacy of anti-CD19 CAR T cell therapy or chemotherapy and transplant in large B cell lymphoma.
Journal: Nature medicine
Published: March 30, 2023
Axicabtagene Ciloleucel in Combination with the 4-1BB Agonist Utomilumab in Patients with Relapsed/Refractory Large B-Cell Lymphoma: Phase 1 Results from ZUMA-11.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 29, 2023
Safety and Efficacy of Axicabtagene Ciloleucel versus Standard of Care in Patients 65 Years of Age or Older with Relapsed/Refractory Large B-Cell Lymphoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 01, 2022
Quality-Adjusted Time without Symptoms or Toxicity: Analysis of Axicabtagene Ciloleucel versus Standard of Care in Patients with Relapsed/Refractory Large B Cell Lymphoma.
Journal: Transplantation and cellular therapy
Published: June 21, 2022
Last Updated: 09/26/2026